Pier Paolo Piccaluga is currently Associate Professor of Pathology at the Department of Experimental, Diagnostic and Specialty Medicine, Bologna University School of Medicine—Institute of Hematology and Medical Oncology, and has been responsible for many years for the Molecular Pathology Laboratory. In 2018, he was appointed for teaching at Queen Mary University of London (UK) and Jomo Kenyatta University of Agriculture and Technology, Nairobi (Kenya). He is the author of several international publications indexed in the Current Contents (234 publications quoted in PubMed, including Nature Medicine, Journal of Clinical Investigation, Journal of Experimental Medicine, Journal of Clinical Oncology, Blood, Lancet Oncology and Lancet Infectious Diseases), with a total impact factor >1000, a mean impact factor >6, and an H-index of 56 (ranked among the VIA-Academy Top Italian Scientists).

Dr. Adel K. El-Naggar is a Professor and Section Chief of Head and Neck Pathology at the University of Texas M.D. Anderson Cancer Center. Dr. El-Naggar is the also the Director of the Head and Neck Pathology Fellowship. He received his M.D. degree from the Ein-Shams School of Medicine, Cairo, Egypt and research and pathology training at Vanderbilt and Case Western-Reserve University in Nashville and Cleveland, Ohio. Dr. El-Naggar is an Editor-in-Chief of the Head and Neck Oncology Journal and a member of several editorial boards of pathology, oncology and head and neck medical journals. He is also a member of national and international committees and cooperative groups in head and neck tumors. Dr. El-Naggar has authored and co-authored 610articles, 55 editorials and 10 book chapters on pathology of the head and neck. His main research efforts are focused on molecular genetic characterization of head and neck and salivary carcinomas and biomarker integration in clinical management of patients with these tumors.

Nira Ben Jonathan is Emeritus Professor of Cancer and cell Biology at the University of Cincinnati, Ohio, USA. She published 180research manuscripts and reviews, contributed 12 chapters to encyclopedias and textbooks, edited several books, and wrote a book on dopamine. She mentored 65 students, clinical fellows, and research scientists. Among her awards are the NIH Research Career Development Award, the Rieveschl Award for Outstanding Scientific Research, and the Edward Merker Lectureship in Translational Endocrinology. She is an elected Fellow of the AAAS, and an elected member of the Royal Society of Medicine, UK. She also was an elected Chairman of the Gordon Research Conference on Prolactin. Over the years, she was a member of numerous Study Sections of the NIH, DOD, and the Komen foundation, and served as the chairman on five NIH Study Sections.

Dr Cho’s main research interests have been focusing on cancer studies to discover biomarkers for cancer diagnosis, treatment prediction and prognostication. As a seasoned researcher, Dr Cho has conducted cancer research in using molecular biology, proteomics, genomics, immunology as well as bioinformatics, his current H-index is 100. Dr. Cho has published more than 600 peer-reviewed papers (Lancet, Lancet Oncology, Annals of Oncology, Lancet Gastroenterology & Hepatology, Advanced Science, Nature Communications, PNAS, Molecular Cancer, Journal of Thoracic Oncology, Journal of the National Cancer Institute, Journal of Extracellular Vesicles, Clinical Cancer Research, Clinical Chemistry, Theranostics, etc.) covering cancer biomarkers, proteomics, non-coding RNA, traditional Chinese medicine, and dozens of books (including “An Omics Perspective on Cancer Research”, “MicroRNAs in Cancer Translational Research”, “Drug Repurposing in Cancer Therapy: Approaches and Applications” and “Supportive Cancer Care with Chinese Medicine”.

Helmut H. Popper , MD, is the professor of Pathology in Department of Pathology, Medical University of Graz, Austria. Prof. Popper is a Pathologist with an additional specialization in Pulmonary and Mediastinal Pathology. He is the leader of the Research Unit for Molecular Lung and Pleura Pathology with a focus on lung cancer but also some interstitial lung diseases. Since 1986, a lung biobank was established to be used for research. He served as President of the Austrian Society of Pathology, is presently Chair of the Education Subcommittee of the European Society of Pathology and Council Member. He serves at the Editorial Board of Virchows Archiv and Journal of Thoracic Oncology and as a reviewer on 33 different Journal devoted to all kinds of lung diseases.

Mary Jo Lechowicz, MD, joined Emory from the Sidney Kimmel Cancer Center at Johns Hopkins University where she completed a post-doctoral fellowship in oncology. Dr. Lechowicz is board certified in medical oncology. Dr. Lechowicz's research interests are in hematologic malignancies. She has been a principal investigator and co-principal investigator on a number of national and international clinical trials involving the treatment of patients with virally related cancers, particularly T-cell non-Hodgkin lymphoma and non-hodgen's lymphoma in particular. Dr. Lechowicz is currently active in the American Society of Clinical Oncology, the Discovery and Developmental Therapeutics Research Program, the American Society of Hematology, the American Medical Association, the American Association of Medical Colleges and the American Association of Cancer Research. She is a member of the Discovery and Developmental Therapeutics Research Program at Winship. Dr. Lechowicz earned her medical degree from SUNY-Syracuse in Syracuse, New York. She completed her internship and residency at Columbia Presbyterian Medical Center in New York, New York where she was also a Chief Resident. She then completed a fellowship at the Sidney Kimmel Cancer Center at Johns Hopkins Hospital in Baltimore, Maryland.

Dr. Gizem Calibasi Kocal is an Associate Professor at the Department of Translational Oncology, Dokuz Eylul University-Institute of Oncology, Turkey. She earned her PhDs in Basic Oncology from Dokuz Eylul University, and in Medical Biochemistry from Istanbul Medipol University. During her PhD studies, she was a pre-doctoral research fellow at Harvard and Stanford Universities, focusing on microfluidic technologies for cancer metastasis. From 2018 to 2020, Dr. Calibasi-Kocal worked as a post-doctoral research fellow at MIT's Koch Institute, researching the effects of diet on intestinal stem cells and cancers. Now, she has been leading a research group focusing on the molecular mechanisms of colorectal cancer, particularly the tumor microenvironment, cancer metabolism, and dietary impacts on cancer biology. Her contributions have earned her awards from TUBITAK, OECI, and EFLM. Dr. Calibasi-Kocal is the Associate Editor of the Journal of Basic and Clinical Health Sciences, and serves on the editorial boards of Artificial Intelligence in Cancer and the Journal of Biology.

He completed his high school education at Istanbul Selimiye Veterinary Health Vocational High School. He graduated from Uludağ University Yenişehir İbrahim Orhan Vocational School, Department of Animal Health and Breeding, with his associate degree. He graduated from Atatürk University Faculty of Veterinary Medicine in 2006. Subsequently, he graduated from Kırıkkale University, Institute of Health Sciences, Department of Physiology in 2017. He also graduated from the Faculty of Law of Kosovo Iliria Royal University (Iliria College) in 2018. From 1998 until 2017, he worked as a Veterinarian, District Manager and Deputy Provincial Director at the Ministry of Agriculture and Forestry. In the field of Endocrinology, he has published articles, projects, and articles on the subjects and fields of Hedonic Hunger, Orthorexia Neurosa, Nutrition according to blood groups, Nutrition in anxiety situations such as Exam Anxiety, circadian nutrition, traditional and complementary medicine, phytotherapy and Aromatherapy, Nutrition and Dietetics, Nursing, Neuroleadership, and climate change. He has books and international papers. He has research on the Examination of Endocrine Response in Nutritional Disorders.

Baher Effat is a Research Professor. National Research Centre, Egypt. Over 36 years of experience in Food and Dairy Bacteriology, he shared and supervised over than 6 Master and Ph.D Thesis in Food and Dairy sciences and more than 69 scientific publications in food and dairy microbiology, functional dairy products , probiotics and propionic acid bacteria and pathogenic bacteria and in Food and Dairy Products. He has shared in national and international programs and projects. He joined many international conferences and workshop, in addition to scientific activities. In addition he awarded for CAS-TWAS Visiting Scholar Fellowship from 03 Aug., 2006 to 31 October 2006. Lecturer in Faculty of Engineering Sciences and Technology, Sabha University, Libya for 3 years from 1994 to 1997.

Dr. med. Ilija Golubović, born in 1989 in Leskovac, graduated from the Faculty of Medicine in Niš in 2014, where he completed his specialization in abdominal surgery in 2020, and works at the Department of Hepatobiliary and Pancreatic Surgery of the Clinic for Digestive Surgery of the University Clinical Center of Niš, where he deals with the treatment of benign and malignant tumor in the abdominal organs. Since 2020, he has a license to work as a doctor in Germany (Die deutsche Approbation als Arzt, Regierungspräsidium Stuttgart). He is a member of the Hilandar Medical Society, as well as the European Association for Endoscopic Surgery (The European Association for Endoscopic Surgery).

Dr Jelena Jeremic is Professor of plastic, reconstructive and aesthetic surgery at the University of Belgrade, School of Medicine, Serbia. She published over 100 research manuscripts and reviews in the field of surgical oncology, skin and soft tissue malignancy, with special interest in melanoma pathology and reconstructive microsurgery. Dr Jeremic is a subspecialist in the field of Oncology, and is mentor of numerous students graduation thesis and post doctoral thesis. She shared national and international projects, and has actively participated in many international conferences and workshops.